Spero Therapeutics, Inc. (SPRO)

1.225 +0.01 (+0.82%) USD  |  NASDAQ  |  Aug 25, 16:00
1.225 0.00 (0.00%) After-Hours: 19:59
More

Spero Therapeutics EPS Estimates for Next Quarter

EPS Estimates for Next Quarter Chart

View EPS Estimates for Next Quarter for SPRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Quarter Chart
Start Trial

Historical EPS Estimates for Next Quarter Data

View and export this data back to 2023. Start Trial.
Date Value
May 19, 2025 --
April 02, 2025 --
February 21, 2025 --
January 30, 2025 --
December 02, 2024 --
November 18, 2024 --
November 04, 2024 --
August 06, 2024 --
August 05, 2024 --
May 16, 2024 --
Date Value
May 15, 2024 --
March 18, 2024 --
March 14, 2024 --
March 13, 2024 --
March 04, 2024 --
February 23, 2024 --
January 03, 2024 --
November 17, 2023 --
November 14, 2023 --
November 13, 2023 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Quarter Range, Past 5 Years

View EPS Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Quarter Benchmarks

View EPS Estimates for Next Quarter Benchmarks
Start Trial
Inovio Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Kura Oncology, Inc. Upgrade
Legend Biotech Corp. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade

EPS Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade